Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure

Pathophysiology of Haemostasis and Thrombosis

Volumn 27, Issue 4, 1997, Pages 163-167

  Matsuo, Takefumi ^a   Koide, Masanobu ^a   Kario, Kazuomi ^a   Suzuki, Shunji ^a   Matsuo, Miyako ^a  

^a HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

Author keywords

Diabetes mellitus; End stage chronic renal failure; Extrinsic coagulation factors; Factor XIIa; Tissue factor pathway inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 12A; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; UREMIA;

AGED; ANTITHROMBIN III; BLOOD COAGULATION FACTORS; DIABETIC NEPHROPATHIES; FACTOR VII; FACTOR VIIA; FACTOR XIIA; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES;

EID: 0031437889     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217449     Document Type: Article

References (14)

1. Kario K, Matsuo T, Yamada T, Na-kao K, Shimano C, Matsuo M: Factor VII hyperactivity in chronic dialysis patients. Thromb Res 1992;67: 105-113.
2. Furie B, Furie BC: Molecular and cellular biology of blood coagulation. N Engl J Med 1992;326:800-806.
3. Mitropoulos KA. Martin JC, Burgess MP, Esnoup MP, Stirling Y, Howarth DJ, Reeves BEA: The increased rate of activation of factor XII in late pregnancy can contribute to the increased reactivity of factor VII. Thromb Hacmost 1990;63: 349-355.
4. Nakamura S, Kamikubo Y, Okaji-ma K, Asakura H, Nakamura K: Plasma tissue factor, its sensitive assay and characterization (abstract). Thromb Haemost 1993;69:744.
5. Kario K, Miyata T, Sakata T, Matsuo T, Kato H: Fluorogenic assay of activated factor VII: Plasma factor Vila levels in relation to arterial cardiovascular disease in Japanese. Ar-tcriosclcr Thromb Vase Biol 1994; 14:265-274.
6. Sandset PM, Larsen ML, Abild-gaard U, Lindahl KA, Odcgaard OR: Chromogcnic substrate assay of extrinsic pathway inhibitor (EP1) levels of the normal population and relation to cholesterol. Blood Coagul Fibrinolysis 1991;2:425-433.
7. Kario K, Matsuo T, Matsuo M, Koide M, Yamada T, Nakamura S, Sakata T, Kato H, Miyata T: Marked increase of activated factor VII in uremic patients. Thromb Haemost 1995;73:763-767.
8. Mitropoulos KA, Martin JC, Stirling Y, Morrisey JH. Cooper JA: Activation of factors XII and VII induced in citrated plasma in the presence of contact surface. Thromb Haemost 1995;73:763-767.
9. Burman JF, Chung HI, Lane DA, Philippou H, Adami A, Lincoln JCR: Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet 1994;344:1192-1993.
10. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T: Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vase Biol 1995;15:1114-1120.
11. Kario K, Matsuo T, Yamada T, Matsuo M: Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis. Thromb Haemost 1994;71:275-279.
12. Koyama T. Nishida K: Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 1994;87:343-347.
13. Takagi M, Wada H, Mukai K, Kiha-ra H, Sano S, Minamikawa K, Waki-ta Y, Nakase T, Nagaya S, Deguchi K, Shirakawa S. Suzuki K: Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis. Blood Coagul Fibrinolysis 1994; 5:713-717.
14. Boisclair MD, Lane DA, Philippou H, Esnouf PE, Sheikh H, Hunt B. Smith KJ: Mechanisms of thrombin generation during surgery and cardiopulmonary bvpass. Blood 1993; 82:3350-3357.